Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: A prospective cohort study by the Kanto Study Group for Cell Therapy

Bone Marrow Transplantation

Volumn 50, Issue 5, 2015, Pages 727-733

  Tanaka, M ^a   Kanamori, H ^a   Matsumoto, K ^a   Tachibana, T ^a,b   Numata, A ^a,c   Ohashi, K ^d   Kobayashi, T ^d   Nakaseko, C ^e   Kanda, Y ^f   Yamazaki, E ^b   Fujisawa, S ^c   Ooi, J ^g   Sakura, T ^h   Aotsuka, N ⁱ   Onoda, M ^j   Machida, S ^k   Kato, J ^l   Usuki, K ^m   Watanabe, R ⁿ   Taguchi, J ^o   Yano, S ^p   Saito, T ^q   Takahashi, S ^g   Sakamaki, H ^c   Okamoto, S ^l   more..

^a KANAGAWA CANCER CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^d TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^e CHIBA UNIVERSITY   (Japan)

^f JICHI MEDICAL UNIVERSITY   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h SAISEIKAI MAEBASHI HOSPITAL   (Japan)

ⁱ NARITA RED CROSS HOSPITAL   (Japan)

^j Chiba Aoba Municipal Hospital   (Japan)

^k TOKAI UNIVERSITY   (Japan)

^l KEIO UNIVERSITY   (Japan)

^m Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

ⁿ SAITAMA MEDICAL UNIVERSITY   (Japan)

^o SHIZUOKA RED CROSS HOSPITAL   (Japan)

^p JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^q GUNMA UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; FERRITIN; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; BLOODSTREAM INFECTION; CANCER MORTALITY; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; COHORT ANALYSIS; EVENT FREE SURVIVAL; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HYPERFERRITINEMIA; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; ALLOGRAFT; BLOOD; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FOLLOW UP; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INCIDENCE; MIDDLE AGED; MORTALITY; MYCOSIS; PREOPERATIVE PERIOD; SURVIVAL RATE;

ADULT; AGED; ALLOGRAFTS; BACTERIAL INFECTIONS; DISEASE-FREE SURVIVAL; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYCOSES; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84928924283     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2015.17     Document Type: Article

References (24)

1. Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, Ito J et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2008; 42: 799-805.
2. Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007; 109: 4586-4588.
3. Alessandrino EP, Della Porta MG, Bacigalupo A, Malcovati L, Angelucci E, Van Lint MT et al. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica 2010; 95: 476-484.
4. Tachibana T, Tanaka M, Takasaki H, Numata A, Maruta A, Ishigatsubo Y et al. Pre-SCT serum ferritin is a prognostic factor in adult AML, but not ALL [letter]. Bone Marrow Transplant 2011; 46: 1268-1269.
5. Tachibana T, Takasaki H, Tanaka M, Maruta A, Hyo R, Ishigatsubo Y et al. Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome. Bone Marrow Transplant 2011; 46: 150-151.
6. Kataoka K, Nannya Y, Hangaishi A, Imai Y, Chiba S, Takahashi T et al. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009; 15: 195-204.
7. Kanda J, Mizumoto C, Ichinohe T, Kawabata H, Saito T, Yamashita K et al. Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2011; 46: 208-216.
8. Tanaka M, Tachibana T, Numata A, Takasaki H, Matsumoto K, Maruta A et al. A prognostic score with pretransplant serum ferritin and disease status predicts outcome following reduced-intensity SCT. Bone Marrow Transplant 2012; 47: 596-597.
9. Tachibana T, Tanaka M, Takasaki H, Numata A, Ito S, Watanabe R et al. Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies. Int J Hematol 2011; 93: 368-374.
10. Altes A, Remacha AF, Sarda P, Sancho FJ, Sureda A, Martino R et al. Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant 2004; 34: 505-509.
11. Bullen JJ, Rogers HJ, Spalding PB, Ward CG. Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol 2006; 55: 251-258.
12. van Asbeck BS, Marx JJ, Struyvenberg A, van Kats JH, Verhoef J. Effect of iron (III) in the presence of various ligands on the phagocytic and metabolic activity of human polymorphonuclear leukocytes. J Immunol 1984; 132: 851-856.
13. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15: 1628-1633.
14. Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2009; 15: 367-369.
15. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
16. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
17. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154.
18. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
19. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013; 48: 452-458.
20. Sahlstedt L, Ebeling F, von Bonsdorff L, Parkkinen J, Ruutu T. Non-transferrinbound iron during allogeneic stem cell transplantation. Br J Haematol 2001; 113: 836-838.
21. Mahindra A, Bolwell B, Sobecks R, Rybicki L, Pohlman B, Dean R et al. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versushost disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. Br J Haematol 2009; 146: 310-316.
22. Lim ZY, Fiaccadori V, Gandhi S, Hayden J, Kenyon M, Ireland R et al. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. Leuk Res 2010; 34: 723-727.
23. Sakamoto S, Kawabata H, Kanda J, Uchiyama T, Mizumoto C, Kondo T et al. Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Int J Hematol 2013; 97: 109-116.
24. Grossekatthofer M, Guclu ED, Lawitschka A, Matthes-Martin S, Mann G, Minkov M et al. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease. Ann Hematol 2013; 92: 1121-1128.